Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Title Genescos Shares Plummet After Downgrade by B Riley Securities

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
MO stock news
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On March 5, 2024, Genesco’s shares took a hit as B. Riley Securities downgraded the stock from Buy to Neutral. This unexpected move caused a 6.4% drop in Genesco’s shares, reflecting investors’ concerns about the company’s future earnings. Consequently, the stock price plummeted by 9.17%, marking a significant decline in value. This event underscores the volatility of the stock market and the impact of analyst ratings on investor sentiment.

CrowdStrike Holdings, Inc. (CRWD) Stock Price Plummets During Regular Trading Hours, Rebounds in After-Hours Trading

On March 5, 2024, CrowdStrike Holdings, Inc. (CRWD) experienced a significant drop in its stock price during regular trading hours, closing at $297.56. The stock decreased by $16.25, representing a 5.18% decline from the previous market close. Despite this drop, CRWD is still trading near the top of its 52-week range and above its 200-day simple moving average, indicating strong performance over a longer period.

However, after-hours trading saw a sharp reversal in CRWD’s fortunes, with the stock price rising by $63.84. This substantial increase more than offset the losses incurred during the regular trading session, highlighting the volatility and unpredictability of the stock market.

CrowdStrike Holdings Inc. (CRWD) Reports Impressive Financial Performance on March 5, 2024

CrowdStrike Holdings Inc. (CRWD) has been making waves in the cybersecurity industry, and its stock performance on March 5, 2024, reflects its growing success. According to data from CNN Money, the company reported total revenue of $2.24 billion for the past year, with a significant increase of 54.4% compared to the previous year.

The company’s net income also saw impressive growth, with a reported net loss of $183.25 million for the year, which is a 21.96% improvement from the previous year.

Earnings per share (EPS) for CrowdStrike showed positive growth as well, with a reported EPS of -$0.79 for the year, marking a 23.96% increase from the previous year.

Overall, CrowdStrike’s strong financial performance on March 5, 2024, reflects the company’s continued success in the cybersecurity industry. With significant increases in revenue, net income, and earnings per share, investors may see CrowdStrike as a promising investment opportunity in the rapidly evolving cybersecurity market.

Tags: CRWD
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Ev clean energy

BGE Partners with ICF to Implement EmPOWER Maryland Program

Unlocking Value: The Economic Potential of Iron-Titanium-Vanadium Projects

Box Board Announces 100 Million Expansion of Stock Repurchase Program

Biotechnology Trading online

Bionano Genomics Exceeds Sales Expectations with 30 Growth

Recommended

Jakks Pacific Reports Disappointing Q4 2023 Earnings

2 years ago
Ecommerce Stock Exchange

Notable Options Market Activity for Shopify

2 years ago
Fannie Mae Stock

Fannie Mae’s Public Offering Plans Derailed by Prominent Investor

3 months ago
Ocugen Stock

Ocugen Shares Face Critical Test Amid Steep Decline

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Trending

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

by Rodolfo Hanigan
February 7, 2026
0

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The...

Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves
  • Deluxe Stock Gains Momentum on Successful Fintech Transition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com